Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

V. La, R. Fujikawa, D. M. Janzen, M. Nunez, L. Bainvoll, L. Hwang, K. Faull, G. Lawson, S. Memarzadeh

Monday, April 3, 2017
Published in Precision Oncology